Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Treating hypertension: who speaks for the patient?

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1.

    Tobe SW, Campbell NRC, Padwal RS, Kahn NA, Singer J. Change in education strategy associated with slippage in Canadian hypertension awareness, treatment and control rates.

  2. 2.

    Tobe SW, Touyz RM, Campbell N. The Canadian Hypertension Education Program—a unique Canadian knowledge translation program. Can J Cardiol. 2007;23:551–5.

    Article  Google Scholar 

  3. 3.

    Hua D, Carter S, Bellerive S, Allu SO, Reid T, Tremblay G, et al. Bridging the gap: innovative knowledge translation and the Canadian Hypertension Education Program. Can J Cardiol. 2012;28:258–61.

    Article  Google Scholar 

  4. 4.

    Onysko J, Maxwell C, Eliasziw M, Zhang JX, Johansen H, Campbell NR. Large increases in hypertension diagnosis and treatment in Canada after a healthcare professional education program. Hypertension. 2006;48:853–60.

    CAS  Article  Google Scholar 

  5. 5.

    Schiffrin EL, Campbell NR, Feldman RD, Kaczorowski J, Lewanczuk R, Padwal R, et al. Hypertension in Canada: past, present and future. Ann Glob Health. 2016;82:288–99.

    Article  Google Scholar 

  6. 6.

    Leung AA, Williams JVA, McAlister FA, Campbell NRC, Padwal RS, Hypertension Canada’s Research and Evaluation Committee. Worsening hypertension awareness, treatment, and control rates in Canadian women between 2007 and 2017. Can J Cardiol. 2020;36:732–9.

    Article  Google Scholar 

  7. 7.

    James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311:507–20.

    CAS  Article  Google Scholar 

  8. 8.

    Wright JT Jr, Fine LJ, Lackland DT, Ogedegbe G, Dennison, Himmelfarb CR. Evidence supporting a systolic blood pressure goal of less than 150 mm Hg in patients aged 60 years or older: the minority view. Ann Intern Med. 2014;160:499–503.

    Article  Google Scholar 

  9. 9.

    Gibbons GH, Shurin SB, Mensah GA, Lauer MS. Refocusing the agenda on cardiovascular guidelines: an announcement from the National Heart, Lung, and Blood Institute. Circulation. 2013;128:1713–5.

    Article  Google Scholar 

  10. 10.

    Qaseem A, Wilt TJ, Rich R, Humphrey LL, Frost J, Forciea MA, Clinical Guidelines Committee of the American College of Physicians and the Commission on Health of the Public and Science of the American Academy of Family Physicians. Pharmacologic treatment of hypertension in adults aged 60 years or older to higher versus lower blood pressure targets: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med. 2017;166:430–7.

    Article  Google Scholar 

  11. 11.

    SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991;265:3255–64.

    Article  Google Scholar 

  12. 12.

    Messerli FH, Hofstetter L, Agabiti-Rosei E, Burnier M, Elliott WJ, Franklin SS, et al. Expertise: no longer a sine qua non for guideline authors? J Hypertens. 2017;35:1564–6.

    CAS  Article  Google Scholar 

  13. 13.

    Messerli FH, Hofstetter L, Agabiti-Rosei E, Burnier M, Elliott WJ, Franklin SS, et al. Expertise: no longer a sine qua non for guideline authors? Hypertension. 2017;70:235–7.

    CAS  Article  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Michael A. Weber.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Weber, M.A., Lackland, D.T. Treating hypertension: who speaks for the patient?. J Hum Hypertens (2021).

Download citation


Quick links